imatinib mesylate
NDC 67184-0533, imatinib mesylate, tablet, from Qilu Pharmaceutical Co., Ltd..
- Product NDC
- 67184-0533
- Status
- Listed
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212135
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0533 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IMATINIB MESYLATE400 mg/1
Pharmacologic classes
Bcr-Abl Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67184-0533-1 | 67184053301 | 30 TABLET in 1 BOTTLE (67184-0533-1) |
| 67184-0533-2 | 67184053302 | 300 TABLET in 1 BOTTLE (67184-0533-2) |
| 67184-0533-3 | 67184053303 | 30 BLISTER PACK in 1 CARTON (67184-0533-3) / 10 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/82eb01e0-8685-4f06-8a72-7663e8ded38f
Use it
Look up 67184-0533 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0533 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67184-0533. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.